MicroPort’s implantable implantable defibrillator and pacemaker spinoff has secured funding in a series C round co-led by its parent company.
Novo led the sustainable materials producer’s series C round, three years after a round backed by investors including Ginkgo Bioworks.
SoftBank Vision Fund 2 has led a round that took the Salesforce Ventures-backed online classroom tool provider’s overall funding to more than $160m.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.